Rongyu is a Ph.D. student in UW Bioengineering. She received her bachelor’s degree in Bioengineering from UCLA in 2017. She is currently working on new technologies to capture and analyze antigen-specific CD4+ T cells in cancer immunotherapy patients. Due to the COVID-19 pandemic, she is also working on associating antigen specificity of SARS-CoV-2 specific T cells with their phenotypes. Her work aims to understand which anti-viral T cell responses lead to immune-protection and how such responses can be anticipated, so as to inform vaccine design.